Sun Pharmaceutical Industries has informed that it enclosed copy of the press release titled ‘LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a PCSK9 Inhibitor, Ex-US and China; Lyrokaul (lerodalcibep) Approved in the EU’ which shall be released after this intimation.
The above information is a part of company’s filings submitted to BSE.